Thursday, February 09, 2017 1:57:22 AM
I believe it is now or never. There are a lot of new nuclear technologies coming out and an appetite to try them. Lightbridge must secure their seat at the table or the other tech will pass them by and they will become obsolete. No means a sure thing and I am concerned that they didn't make their 10/31/16 milestone regarding signing up the US Utility and now may miss the 3/31 one for signing a binding contract with Areva. Aspire Capital set these milestones. I don't expect the upcoming conferences themselves to move the stock. A PR mentioning a signed contract would do that, however it will be good to get an update. I am uncertain if I should take a loss or keep holding. I plan to hold through earnings. I don't think that's going to cause a big move either way. But if they keep stringing us along with promises of deals and testing in future quarters I'll probably give up.
Recent LTBR News
- Lightbridge to Hold Business Update & First Quarter 2024 Earnings Conference Call on Friday, May 10th at 11 a.m. ET • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Ambassador Thomas Graham, Jr. Appointed As Chairman Emeritus of Lightbridge Corporation • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Lightbridge Senior Executives Assume Key Positions in Prestigious Nuclear Energy Industry Groups • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Lightbridge Achieves Critical Fabrication Development Milestone by Demonstrating the Extrusion Process for Uranium-Zirconium Samples • GlobeNewswire Inc. • 03/18/2024 10:00:00 AM
- Lightbridge Announces Upcoming Nuclear Events • GlobeNewswire Inc. • 03/13/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/08/2024 10:00:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/04/2024 10:21:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 04:02:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 04:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 04:01:54 PM
- Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
- Lightbridge CEO Seth Grae Issues Update Letter to Shareholders • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- Lightbridge to Hold Business Update & Fiscal Year 2023 Earnings Conference Call on Thursday, February 29 at 10 a.m. ET • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 04:01:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 04:01:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 04:00:51 PM
- Lightbridge Announces Upcoming Industry Event and Media Interview • GlobeNewswire Inc. • 01/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 03:45:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 03:45:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/28/2023 03:44:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:00:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 01:00:34 PM
- Lightbridge and Centrus Energy Enter into a Contract to Conduct a FEED Study for a Lightbridge Pilot Fuel Fabrication Facility in Piketon, Ohio • PR Newswire (US) • 12/07/2023 11:30:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM